Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Journal of Translational Medicine
|
August 17, 2006
Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma
Svetomir N Markovic, Allan B Dietz, Carl W Greiner, et al.
Cancer
|
October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
Robert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437
Monica M Reinholz, Kathleen A Kitzmann, Kathleen Tenner, et al.
American Journal of Clinical Oncology
|
January 30, 2013
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675
Roxana S Dronca, Jacob B Allred, Domingo G Perez, et al.
Melanoma Research
|
November 10, 2020
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target
Riyue Bao, Oliver Surriga, Daniel J Olson, et al.
Blood
|
April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Blood
|
September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
Angela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
The Oncologist
|
November 10, 2018
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
Myra Barginear, Amylou C Dueck, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Leukemia & Lymphoma
|
November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin
Jeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Journal of Translational Medicine
|
August 17, 2006
Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma
Svetomir N Markovic, Allan B Dietz, Carl W Greiner, et al.
Cancer
|
October 19, 2017
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma
Robert R McWilliams, Jacob B Allred, Jessica A Slostad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437
Monica M Reinholz, Kathleen A Kitzmann, Kathleen Tenner, et al.
American Journal of Clinical Oncology
|
January 30, 2013
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675
Roxana S Dronca, Jacob B Allred, Domingo G Perez, et al.
Melanoma Research
|
November 10, 2020
Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target
Riyue Bao, Oliver Surriga, Daniel J Olson, et al.
Blood
|
April 13, 2006
Lenalidomide therapy in myelofibrosis with myeloid metaplasia
Ayalew Tefferi, Jorge Cortes, Srdan Verstovsek, et al.
Blood
|
September 30, 2006
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
Angela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust, et al.
The Oncologist
|
November 10, 2018
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
Myra Barginear, Amylou C Dueck, Jacob B Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Dan P Zandberg, Jacob B Allred, Ari J Rosenberg, et al.
Leukemia & Lymphoma
|
November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin
Jeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Page
of 8